Neurim Partners Meeting 2025
We were excited to bring together our international partners once again for a productive Partners Meeting, centered on strategic direction, knowledge sharing, and collaboration, all in support of advancing care with Slenyto for children with ASD, NGDs and our newly approved indication in the EU for ADHD.